CFGS
NVS icon

Concourse Financial Group Securities’s Novartis NVS Stock Holding History

Concourse Financial Group Securities’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,981
Closed -$194K – 1399
2024
Q4 		$194K Buy
1,981
+896
+83% +$95.5K 0.01% 730
2024
Q3 		$125K Sell
1,085
-131
-11% -$14.9K 0.01% 882
2024
Q2 		$129K Sell
1,216
-2,091
-63% -$210K 0.01% 846
2024
Q1 		$332K Sell
3,307
-18
-0.5% -$1.85K 0.02% 526
2023
Q4 		$336K Sell
3,325
-459
-12% -$44.3K 0.02% 517
2023
Q3 		$385K Sell
3,784
-69
-2% -$7K 0.03% 464
2023
Q2 		$389K Sell
3,853
-2,401
-38% -$240K 0.03% 480
2023
Q1 		$575K Sell
6,254
-43
-0.7% -$3.75K 0.04% 408
2022
Q4 		$571K Sell
6,297
-469
-7% -$39.5K 0.05% 385
2022
Q3 		$514K Sell
6,766
-377
-5% -$31.3K 0.05% 349
2022
Q2 		$604K Buy
7,143
+431
+6% +$37.8K 0.05% 357
2022
Q1 		$589K Sell
6,712
-5,214
-44% -$451K 0.04% 387
2021
Q4 		$1.04M Buy
11,926
+1,458
+14% +$121K 0.06% 316
2021
Q3 		$856K Buy
10,468
+1,720
+20% +$155K 0.05% 349
2021
Q2 		$798K Buy
8,748
+1,417
+19% +$126K 0.05% 346
2021
Q1 		$627K Sell
7,331
-142
-2% -$12.7K 0.04% 376
2020
Q4 		$706K Buy
7,473
+3,295
+79% +$288K 0.05% 316
2020
Q3 		$363K Buy
4,178
+2,427
+139% +$210K 0.03% 395
2020
Q2 		$153K Sell
1,751
-102
-6% -$8.8K 0.01% 582
2020
Q1 		$153K Buy
1,853
+128
+7% +$11.4K 0.02% 530
2019
Q4 		$163K Buy
1,725
+1,171
+211% +$105K 0.02% 555
2019
Q3 		$48K Sell
554
-1,766
-76% -$159K 0.01% 634
2019
Q2 		$212K Sell
2,320
-309
-12% -$26.2K 0.02% 460
2019
Q1 		$226K Buy
2,629
+1,011
+62% +$81.2K 0.02% 443
2018
Q4 		$124K Buy
1,618
+923
+133% +$71.8K 0.01% 575
2018
Q3 		$54K Buy
+695
New +$51.4K 0.02% 576

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Concourse Financial Group Securities's NVS Position: Q1 2025 in Review

Concourse Financial Group Securities sold out of Novartis (NVS) in Q1 2025, closing a stake of 1,981 shares — an estimated $194K sold.

Concourse Financial Group Securities first reported a position in NVS in Q3 2018 and held it in 26 quarters. The position peaked at $1.04M in Q4 2021. 1,357 funds tracked by Wall St. Rank hold NVS as of Q1 2025.

  • Concourse Financial Group Securities reported no remaining Novartis position as of Q1 2025 after selling out during the quarter.
  • Concourse Financial Group Securities sold 1,981 Novartis shares in Q1 2025, an estimated $194K.
  • Concourse Financial Group Securities first reported a position in Novartis in Q3 2018 and held it in 26 quarters.
  • Concourse Financial Group Securities's Novartis position peaked at $1.04M in Q4 2021.
  • 1,357 funds tracked by Wall St. Rank held Novartis as of Q1 2025.

Based on Concourse Financial Group Securities's 13F filing for Q1 2025.